FDA
approval
· 2022-01-28
FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for a combined oral contraceptive containing norethindrone, ethinyl estradiol, and ferrous fumarate, submitted by My…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)